Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules
Objective To develop and validate an interpretable machine learning (ML) model for predicting malignant risk in patients with breast nodules using serum lipid biomarkers. Methods This retrospective study included 899 patients with breast nodules (236 malignant) admitted between March 2022 and December 2024. Patients we...